Skip to main content

Day: September 28, 2024

Digicann Ventures Signs Definitive Agreement for Proposed RTO Transaction with 3Win Corp.

Written by Customer Service on . Posted in Mergers And Acquisitions.

/ Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, Sept. 28, 2024 (GLOBE NEWSWIRE) — Digicann Ventures Ltd. (“Digicann” or the “Company”) (CSE: DCNN) (OTCPK: AGFAF), a company focused on opportunities within and outside of the cannabis industry, announces that, further to its news release dated August 2, 2024, it has signed a definitive Business Combination Agreement (the “Agreement“) dated September 28, 2024 with 3Win Corp. (“3Win”) in respect of a transaction that would result in the reverse take-over (the “RTO”) of Digicann by 3Win (the “Proposed Transaction“) to ultimately form the resulting issuer (the “Resulting Issuer“). If completed, it is expected that the Proposed Transaction will constitute a “fundamental...

Continue reading

Enliven Therapeutics Announces Positive Data Update from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia

Written by Customer Service on . Posted in Public Companies.

Updated Phase 1 data presented at ESH-iCMLf 26th Annual John Goldman Conference Reported cumulative MMR rate of 44% (8/18) by 24 weeks, with stable or deepening responses between weeks 12 and 24, which continues to compare favorably to precedent Phase 1 trials of approved BCR::ABL1 TKIs ELVN-001 remains well-tolerated with no dose reductions reported with 39 patients enrolled and a median treatment duration of 20 weeks at cutoff BOULDER, Colo., Sept. 28, 2024 (GLOBE NEWSWIRE) — Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced updated, positive data from the Phase 1 clinical trial evaluating ELVN-001 in patients with chronic myeloid leukemia (CML) that has failed, or the patient is...

Continue reading

Nokia selected by Vodafone Idea as major 4G and 5G partner in India

Written by Customer Service on . Posted in Public Companies.

Press Release Nokia selected by Vodafone Idea as major 4G and 5G partner in India  Nokia and Vodafone Idea to deploy 5G network across major Indian cities; Deal includes modernizing and expanding the 4G network. Nokia to supply equipment from its energy-efficient AirScale portfolio including its MantaRay SON solution for network optimization and automation. Deal will bring premium connectivity to Vodafone Idea’s subscribers.28 September 2024Espoo, Finland – Nokia today announced that it has been awarded a three-year deal by Vodafone Idea Limited (VIL) to deploy 4G and 5G equipment. The agreement includes the modernization and expansion of VIL’s 4G network of which Nokia is already a major supplier. The deployment will deliver premium connectivity to 200 million VIL customers. Nokia will increase its market share and replace the incumbent...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.